United States (US) Neuromodulation Market (2025-2031) | Companies, Size & Revenue, Trends, Industry, Share, Growth, Competitive Landscape, Analysis, Segmentation, Forecast, Outlook, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Neuromodulation Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Neuromodulation Market - Industry Life Cycle

3.4 United States (US) Neuromodulation Market - Porter's Five Forces

3.5 United States (US) Neuromodulation Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Neuromodulation Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F

3.7 United States (US) Neuromodulation Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders and chronic pain conditions in the US.

4.2.2 Technological advancements and innovations in neuromodulation devices.

4.2.3 Growing acceptance and adoption of neuromodulation therapies among patients and healthcare providers.

4.3 Market Restraints

4.3.1 High cost associated with neuromodulation treatments.

4.3.2 Stringent regulatory requirements for approval of neuromodulation devices.

4.3.3 Limited reimbursement policies for neuromodulation procedures.

6.1 United States (US) Neuromodulation Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Neuromodulation Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Neuromodulation Market Revenues & Volume, By Internal Neuromodulation, 2021- 2031F

6.1.4 United States (US) Neuromodulation Market Revenues & Volume, By External Neuromodulation, 2021- 2031F

6.2 United States (US) Neuromodulation Market, By Biomaterial

6.2.1 Overview and Analysis

6.2.2 United States (US) Neuromodulation Market Revenues & Volume, By Metallic Biomaterials, 2021- 2031F

6.2.3 United States (US) Neuromodulation Market Revenues & Volume, By Polymeric Biomaterials, 2021- 2031F

6.2.4 United States (US) Neuromodulation Market Revenues & Volume, By Ceramic Biomaterials, 2021- 2031F

6.3 United States (US) Neuromodulation Market, By Application

6.3.1 Overview and Analysis

6.3.2 United States (US) Neuromodulation Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.3.3 United States (US) Neuromodulation Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.3.4 United States (US) Neuromodulation Market Revenues & Volume, By Depression, 2021- 2031F

6.3.5 United States (US) Neuromodulation Market Revenues & Volume, By Dystonia, 2021- 2031F

6.3.6 United States (US) Neuromodulation Market Revenues & Volume, By Pain Management, 2021- 2031F

6.3.7 United States (US) Neuromodulation Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Neuromodulation Market Export to Major Countries

7.2 United States (US) Neuromodulation Market Imports from Major Countries

8.1 Patient satisfaction rates with neuromodulation therapies.

8.2 Number of FDA approvals for new neuromodulation devices.

8.3 Adoption rates of neuromodulation treatments by healthcare facilities.

8.4 Average waiting time for neuromodulation procedures.

8.5 Number of clinical trials and research studies conducted on neuromodulation therapies.

9.1 United States (US) Neuromodulation Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Neuromodulation Market Opportunity Assessment, By Biomaterial, 2021 & 2031F

9.3 United States (US) Neuromodulation Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Neuromodulation Market Revenue Share, By Companies, 2024

10.2 United States (US) Neuromodulation Market Competitive Benchmarking, By Operating and Technical Parameters